Cancer Incidence, Mortality Lower Among Hispanics

This article originally appeared here.
Share this content:
Cancer Incidence, Mortality Lower Among Hispanics
Cancer Incidence, Mortality Lower Among Hispanics

WEDNESDAY, Sept. 16, 2015 (HealthDay News) -- Hispanics have lower cancer incidence and death rates than non-Hispanic whites, according to a study published online Sept. 16 in CA: A Cancer Journal for Clinicians.

Rebecca L. Siegel, M.P.H., from the American Cancer Society in Atlanta, and colleagues used national data to report on cancer statistics for Hispanics.

The researchers estimated that there would be 125,900 new cancer cases diagnosed and 37,800 cancer deaths among Hispanics in 2015. Compared with non-Hispanic whites, Hispanics have 20 percent lower incidence rates and 30 percent lower death rates for all cancers combined. During adolescence (ages 15 to 19), death rates are slightly higher for Hispanics. Cancer rates vary with country of origin, with the lowest in Mexicans, except for infection-associated cancers. Hispanic men have liver cancer incidence rates that are twice those in non-Hispanic white men; these rates doubled from 1992 to 2012, but since 2003, rates in men younger than 50 decreased by 43 percent. Differences in exposure to cancer-causing infectious agents, rates of screening, and lifestyle patterns account for differences in cancer rates for Hispanics and non-Hispanic whites.

"Strategies for reducing cancer risk in Hispanic populations include increasing the uptake of preventive services (e.g., screening and vaccination) and targeted interventions to reduce obesity, tobacco use, and alcohol consumption," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »